NM_000169.3:c.643_645delAATinsTCG

Variant summary

Our verdict is Pathogenic.
+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 14 classification points (ACMG Germline Pathogenicity v2019). PS1_Very_StrongPM1PM2PM5

The NM_000169.3(GLA):c.643_645delAATinsTCG (p.Asn215Ser) variant causes a missense change. Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.02). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.N215K: Likely_pathogenic (ClinVar VariationId 3910027, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.N215D: Uncertain_significance (ClinVar VariationId 4087448, 1 star); p.N215H: Uncertain_significance (ClinVar VariationId 179331, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 23)

Consequence

GLA
NM_000169.3 missense

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 8.02

Publications

0 publications found
Variant links:
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
GLA Gene-Disease associations (from GenCC):
  • Fabry disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Natera, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet, ClinGen
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000169.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 14 points.

PS1Same amino acid change as known pathogenic
Same AA change, ≥2-star ClinVar pathogenic — very strong (PS1); ClinVar contains 1 P/LP entry with the same amino acid change (highest review level: 2 stars).
PM1Mutational hot spot or critical domain
UniProt domain with ≥4 pathogenic missense and OR ≥ 5 vs. background — hotspot (PM1); In-domain: 40 pathogenic, 0 benign rare missense variants (OR vs. background: 405.0).; ±8 AA neighbourhood: 22 pathogenic, 0 benign (OR vs. background: 225.0).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (threshold 0.0001) — PM2 moderate.
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.N215K: Likely_pathogenic (ClinVar VariationId 3910027, 1 star); Other variants at the same amino acid residue (not pathogenic): p.N215D: Uncertain_significance (ClinVar VariationId 4087448, 1 star); p.N215H: Uncertain_significance (ClinVar VariationId 179331, 2 stars)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000169.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

GLA NM_000169.3
MANE Select
HGVSc / HGVSpc.643_645delAATinsTCGp.Asn215Ser
Exon rankN/A
missense
Prot: NP_000160.1UniProt: P06280Q53Y83
GLA NM_001406747.1
HGVSc / HGVSpc.766_768delAATinsTCGp.Asn256Ser
Exon rankN/A
missense
Prot: NP_001393676.1UniProt: A0A3B3IUC4
GLA NM_001406748.1
HGVSc / HGVSpc.643_645delAATinsTCGp.Asn215Ser
Exon rankN/A
missense
Prot: NP_001393677.1UniProt: A0A6Q8PHD1

Ensembl Transcripts

GLA ENST00000218516.4
TSL:1MANE Select
HGVSc / HGVSpc.643_645delAATinsTCGp.Asn215Ser
Exon rankN/A
missense
Prot: ENSP00000218516.4UniProt: P06280
RPL36A-HNRNPH2 ENST00000409170.3
TSL:4
HGVSc / HGVSpc.300+3484_300+3486delATTinsCGA
Exon rankIntron 4 of 4
intron
Prot: ENSP00000386655.4UniProt: H7BZ11
GLA ENST00000649178.1
HGVSc / HGVSpc.766_768delAATinsTCGp.Asn256Ser
Exon rankN/A
missense
Prot: ENSP00000498186.1UniProt: A0A3B3IUC4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 2 sources
GnomAD3 genomes
Cov:23
GnomAD4 genome
Cov:23
Showing 2 sources

ClinVar

Not reported in ClinVar

Computational Scores

PhyloP100
Pathogenic8.0
Showing 1 of 1 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.